Lyons Wealth Management’s AbbVie ABBV Stock Holding History

Lyons Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-8,000	Closed	-$7K	–	66
2013 Q4	$7K	Buy	+8,000	New	+$393K	0.01%	59

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lyons Wealth Management's ABBV Position: Q1 2017 in Review

Lyons Wealth Management sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 12,202 shares — an estimated $764K sold.

Lyons Wealth Management first reported a position in ABBV in Q3 2013 and held it in 8 quarters. The position peaked at $1.13M in Q4 2014. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

Lyons Wealth Management reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
Lyons Wealth Management sold 12,202 AbbVie shares in Q1 2017, an estimated $764K.
Lyons Wealth Management first reported a position in AbbVie in Q3 2013 and held it in 8 quarters.
Lyons Wealth Management's AbbVie position peaked at $1.13M in Q4 2014.
1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Lyons Wealth Management's 13F filing for Q1 2017, filed 15 May 2017.